Literature DB >> 21841309

OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.

Alexander David Barrow1, Nicolas Raynal, Thomas Levin Andersen, David A Slatter, Dominique Bihan, Nicholas Pugh, Marina Cella, Taesoo Kim, Jaerang Rho, Takako Negishi-Koga, Jean-Marie Delaisse, Hiroshi Takayanagi, Joseph Lorenzo, Marco Colonna, Richard W Farndale, Yongwon Choi, John Trowsdale.   

Abstract

Osteoclasts are terminally differentiated leukocytes that erode the mineralized bone matrix. Osteoclastogenesis requires costimulatory receptor signaling through adaptors containing immunoreceptor tyrosine-based activation motifs (ITAMs), such as Fc receptor common γ (FcRγ) and DNAX-activating protein of 12 kDa. Identification of these ITAM-containing receptors and their ligands remains a high research priority, since the stimuli for osteoclastogenesis are only partly defined. Osteoclast-associated receptor (OSCAR) was proposed to be a potent FcRγ-associated costimulatory receptor expressed by preosteoclasts in vitro, but OSCAR lacks a cognate ligand and its role in vivo has been unclear. Using samples from mice and patients deficient in various ITAM signaling pathways, we show here that OSCAR costimulates one of the major FcRγ-associated pathways required for osteoclastogenesis in vivo. Furthermore, we found that OSCAR binds to specific motifs within fibrillar collagens in the ECM that become revealed on nonquiescent bone surfaces in which osteoclasts undergo maturation and terminal differentiation in vivo. OSCAR promoted osteoclastogenesis in vivo, and OSCAR binding to its collagen motif led to signaling that increased numbers of osteoclasts in culture. Thus, our results suggest that ITAM-containing receptors can respond to exposed ligands in collagen, leading to the functional differentiation of leukocytes, which provides what we believe to be a new concept for ITAM regulation of cytokine receptors in different tissue microenvironments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21841309      PMCID: PMC3163954          DOI: 10.1172/JCI45913

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

1.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

Authors:  A Bouchon; F Facchetti; M A Weigand; M Colonna
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

3.  Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.

Authors:  Y Y Kong; U Feige; I Sarosi; B Bolon; A Tafuri; S Morony; C Capparelli; J Li; R Elliott; S McCabe; T Wong; G Campagnuolo; E Moran; E R Bogoch; G Van; L T Nguyen; P S Ohashi; D L Lacey; E Fish; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

4.  Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.

Authors:  Ge Ma; Ping-Ying Pan; Samuel Eisenstein; Celia M Divino; Clifford A Lowell; Toshiyuki Takai; Shu-Hsia Chen
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

5.  A molecular analysis of NKT cells: identification of a class-I restricted T cell-associated molecule (CRTAM).

Authors:  J Kennedy; A P Vicari; V Saylor; S M Zurawski; N G Copeland; D J Gilbert; N A Jenkins; A Zlotnik
Journal:  J Leukoc Biol       Date:  2000-05       Impact factor: 4.962

6.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 7.  Alternative activation of macrophages: mechanism and functions.

Authors:  Siamon Gordon; Fernando O Martinez
Journal:  Immunity       Date:  2010-05-28       Impact factor: 31.745

Review 8.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

9.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.

Authors:  Kandice R Levental; Hongmei Yu; Laura Kass; Johnathon N Lakins; Mikala Egeblad; Janine T Erler; Sheri F T Fong; Katalin Csiszar; Amato Giaccia; Wolfgang Weninger; Mitsuo Yamauchi; David L Gasser; Valerie M Weaver
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 10.  Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation.

Authors:  Takako Negishi-Koga; Hiroshi Takayanagi
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

View more
  81 in total

1.  Collagen binding to OSCAR: the odd couple.

Authors:  Bo An; Barbara Brodsky
Journal:  Blood       Date:  2016-02-04       Impact factor: 22.113

2.  Collagen induces maturation of human monocyte-derived dendritic cells by signaling through osteoclast-associated receptor.

Authors:  Heidi S Schultz; Louise M Nitze; Louise H Zeuthen; Pernille Keller; Albrecht Gruhler; Jesper Pass; Jianhe Chen; Li Guo; Andrew J Fleetwood; John A Hamilton; Martin W Berchtold; Svetlana Panina
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 3.  Discoidin domain receptors: Micro insights into macro assemblies.

Authors:  Gunjan Agarwal; Adam W Smith; Blain Jones
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-06-21       Impact factor: 4.739

4.  TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.

Authors:  Karel Otero; Masahiro Shinohara; Haibo Zhao; Marina Cella; Susan Gilfillan; Angela Colucci; Roberta Faccio; F Patrick Ross; Steve L Teitelbaum; Hiroshi Takayanagi; Marco Colonna
Journal:  J Immunol       Date:  2012-02-06       Impact factor: 5.422

5.  Nanoparticulate mineralized collagen glycosaminoglycan materials directly and indirectly inhibit osteoclastogenesis and osteoclast activation.

Authors:  Xiaoyan Ren; Qi Zhou; David Foulad; Marley J Dewey; David Bischoff; Timothy A Miller; Dean T Yamaguchi; Brendan A C Harley; Justine C Lee
Journal:  J Tissue Eng Regen Med       Date:  2019-04-15       Impact factor: 3.963

6.  Transcriptional profiling of intramembranous and endochondral ossification after fracture in mice.

Authors:  Brandon A Coates; Jennifer A McKenzie; Evan G Buettmann; Xiaochen Liu; Paul M Gontarz; Bo Zhang; Matthew J Silva
Journal:  Bone       Date:  2019-07-29       Impact factor: 4.398

7.  Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery.

Authors:  Christian E Jacome-Galarza; Sun-Kyeong Lee; Joseph A Lorenzo; Hector Leonardo Aguila
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 8.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 9.  Molecular and cellular basis of bone resorption.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2014-09-16

Review 10.  A Comprehensive Review of Immunoreceptor Regulation of Osteoclasts.

Authors:  Mary Beth Humphrey; Mary C Nakamura
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.